Home LiteratureArticle Details
PMID: 4880674 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article

A double blind study of 1-dopa treatment in Parkinson's disease.

European neurology ·Vol. 1 ·No. 3 ·1968-00-00 ·Pages 180-91

Rinne UK, Sonninen V

Abstract

暂无摘要

MeSH Terms
Blood Pressure Clinical Trials as Topic Dihydroxyphenylalanine/adverse effects,therapeutic use Extrapyramidal Tracts/metabolism Female Humans Male Middle Aged Movement Paralysis Parkinson Disease/drug therapy,surgery Parkinson Disease, Postencephalitic/drug therapy Pulse Reaction Time Transducers Tremor/drug therapy
Chemicals
Dihydroxyphenylalanine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rinne U K
Sonninen V
Article Info
Journal
European neurology
Abbr.
Eur Neurol
ISSN
0014-3022
DOI
10.1159/000113660
Published
1968-00-00
Pages
180-91
Language
English
Region
Switzerland
NLM ID
0150760
Subset
IM
External Links
PubMed source DOI: 10.1159/000113660 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2